www.gurufocus.com/stock/MNK

Mallinckrodt PLC (MNK) Stock Analysis, 10 Years Financial Analysis, Interactive Charts, Stock Valuations, Value Investing.

www.thelayoff.com/mallinckrodt?sort=active

Mallinckrodt PLC Layoffs: Downsizing related discussion, postings, questions and answers.

www.bizjournals.com/washington/news/2018/02/13/sucampo-pharmaceuticals-closes-on-its-1-2b-sale-to.html

Feb 13, 2018 ... Rockville-based Sucampo Pharmaceuticals Inc. has officially been sold to U.K. pharmaceutical giant Mallinckrodt PLC. The $1.2 billion deal, ...

stockinvest.us/technical-analysis/MNK

Technical stock forecast for MNK: The Mallinckrodt plc stock holds several negative signals and despite the positive trend we believe Mallinckrodt plc will ...

www.theglobeandmail.com/investing/markets/stocks/MNK-N

Detailed price information for Mallinckrodt Plc (MNK-N) from The Globe and Mail including charting and trades.

www.themedicinescompany.com/investors/news/medicines-company-completes-divestiture-its-hemostasis-portfolio-mallinckrodt-plc

Feb 1, 2016 ... ... Medicines Company (NASDAQ:MDCO) today announced that it has completed the divestiture of its hemostasis portfolio to Mallinckrodt plc.

www.sec.gov/Archives/edgar/data/1567892/000156789215000047/mnk10-k92515.htm

Mallinckrodt plc and its subsidiaries (collectively, "Mallinckrodt" or "the Company" ), is a global specialty biopharmaceutical and nuclear imaging business that ...

phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjkxMzM5fENoaWxkSUQ9NDAyMjQwfFR5cGU9MQ==&t=1

Apr 3, 2018 ... The directors have elected to prepare the Irish statutory Mallinckrodt plc group consolidated financial statements in accordance with Section ...

www.businesswire.com/news/home/20140319005805/en/Mallinckrodt-plc-Completes-1.4-Billion-Acquisition-Cadence

Mar 19, 2014 ... Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceuticals company, today announced the successful completion of its ...